Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: A study from the population-based PROFILES registry

Annals of Hematology

Volumn 93, Issue 5, 2014, Pages 811-819

  Van Der Poel, M W M ^a   Oerlemans, S ^b,c   Schouten, H C ^a   Mols, F ^b,c   Pruijt, J F M ^d   Maas, H ^e   Van De Poll Franse, L V ^b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d JEROEN BOSCH HOSPITAL   (Netherlands)

^e Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Diffuse large B cell lymphoma; Elderly; Population based; Quality of life

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COGNITION; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DYSPNEA; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE CORE 30; FEMALE; FINANCIAL MANAGEMENT; GROUPS BY AGE; HEALTH STATUS; HUMAN; LARGE CELL LYMPHOMA; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COGNITION; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; SEX FACTORS; SOCIAL CLASS; SOCIAL PARTICIPATION; SURVIVORS;

EID: 84898878175     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1980-1     Document Type: Article

References (42)

1. KWF kankerbestrijding, Signaleringcommissie Kanker. Kanker in Nederland tot 2020. Trends and Prognoses (in Dutch). http://www.kwfkankerbestrijding.nl
2. US National Coalition for Cancer Survivorship (2013) http://www. canceradvocacy.org. Accessed 29 May 2013
3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235-242
4. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferme C et al (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23(18):4117-4126
5. van de Schans SA, Wymenga AN, van Spronsen DJ, Schouten HC, Coebergh JW, Janssen-Heijnen ML (2012) Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. Ann Oncol 23(5):1280-1286
6. Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG et al (2001) Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study. Ann Hematol 80(3):155-159
7. Thieblemont C, Grossoeuvre A, Houot R, Broussais-Guillaumont F, Salles G, Traulle C et al (2008) Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol 19(4):774-779
8. Peters FP, Fickers MM, Erdkamp FL, Wals J, Wils JA, Schouten HC (2001) The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates. Ann Hematol 80(7):406-410
9. Kobayashi Y, Miura K, Hojo A, Hatta Y, Tanaka T, Kurita D et al (2011) Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol 137(7):1079-1084
10. Heutte N, Haioun C, Feugier P, Coiffier B, Tilly H, Ferme C et al (2011) Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant. Leuk Lymphoma 52(7):1239-1248
11. Smith SK, Zimmerman S, Williams CS, Zebrack BJ (2009) Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer 115(14):3312-3323
12. Jerkeman M, Kaasa S, Hjermstad M, Kvaloy S, Cavallin-Stahl E (2001) Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol 18(1):85-94
13. Merli F, Bertini M, Luminari S, Mozzana R, Berte R, Trottini M et al (2004) Quality of life assessment in elderly patients with aggressive non-Hodgkin's lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi. Haematologica 89(8):973-978
14. Smith SK, Crespi CM, Petersen L, Zimmerman S, Ganz PA (2010) The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors. Psychooncology 19(12):1259-1267
15. Mols F, Aaronson NK, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Lybeert ML et al (2007) Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer 109(8):1659-1667
16. Doorduijn J, Buijt I, Holt B, Steijaert M, Uyl-de Groot C, Sonneveld P (2005) Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy. Eur J Haematol 75(2):116-123
17. Persson L, Larsson G, Ohlsson O, Hallberg IR (2001) Acute leukaemia or highly malignant lymphoma patients' quality of life over two years: a pilot study. Eur J Cancer Care (Engl) 10(1):36-47
18. Geffen DB, Blaustein A, Amir MC, Cohen Y (2003) Post-traumatic stress disorder and quality of life in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma in Israel. Leuk Lymphoma 44(11):1925-1929
19. Fritz APC, Jack A et al (2000) International classification of diseases for oncology, 3rd edn. World Health Organisation, Geneva
20. van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK et al (2011) The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer 47(14):2188-2194
21. van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM et al (2011) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 47(5):667-675
22. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
23. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156-163
24. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29(1):89-96
25. Hall AE, Boyes AW, Bowman J, Walsh RA, James EL, Girgis A (2012) Young adult cancer survivors' psychosocial well-being: a cross-sectional study assessing quality of life, unmet needs, and health behaviors. Support Care Cancer 20(6):1333-1341
26. Bifulco G, De Rosa N, Tornesello ML, Piccoli R, Bertrando A, Lavitola G et al (2012) Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. Gynecol Oncol 124(3):444-451
27. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14):3348-3356
28. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I et al (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109(9):1905-1913
29. Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S et al (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13(9):1387-1397
30. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292-2299
31. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104(11):2499-2507
32. Jensen RE, Arora NK, Bellizzi KM, Rowland JH, Hamilton AS, Aziz NM et al (2013) Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 119(3):672-680
33. Zebrack BJ, Yi J, Petersen L, Ganz PA (2008) The impact of cancer and quality of life for long-term survivors. Psychooncology 17(9):891-900
34. Brandt J, Dietrich S, Meissner J, Neben K, Ho AD, Witzens-Harig M (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 51(11):2012-2020
35. Mols F, Thong MS, Vissers P, Nijsten T, van de Poll-Franse LV (2012) Socio-economic implications of cancer survivorship: results from the PROFILES registry. Eur J Cancer 48(13):2037-2042
36. Mols F, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Aaronson NK, Lybeert ML et al (2006) Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 42(16):2794-2801
37. Mols F, Thong MS, Vreugdenhil G, van de Poll-Franse LV (2009) Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology 18(12):1252-1260
38. Hasselblom S, Stenson M, Werlenius O, Sender M, Lewerin C, Hansson U et al (2012) Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era. Leuk Lymphoma 53(3):394-399
39. Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS (2008) Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Clin Oncol 26(19):3159-3165
40. Lee L, Crump M, Khor S, Hoch JS, Luo J, Bremner K et al (2012) Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis. Br J Haematol 158(4):481-488
41. Lin TL, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH et al (2012) The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma. Ann Hematol 91(9):1383-1391
42. Griffiths RI, Gleeson ML, Mikhael J, Dreyling MH, Danese MD (2012) Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma. Cancer 118(24):6079-6088